Daniel Furlong, MD
Urology · Charleston, SCNPI 1083060859
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Urovant Sciences Inc at 39.4% of the total. Reporting peaked in 2022 at $3,082 and has fallen 85.2% since, to $456 in 2025.
Across 46 payments — averaging $154.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urovant Sciences Inc$3K
- Procept Biorobotics Corporation$2K
- Boston Scientific$1K
- Axonics, Inc.$218
- Teleflex LLC$189
- Urogen Pharma, Inc.$61
- plus $16 from 1 others
What the payments were for
- Consulting fees$2,65037%
- Travel & lodging$2,00228%
- Food & beverage$2,45535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urovant Sciences Inc | 2 | $2,800 |
| Procept Biorobotics Corporation | 16 | $2,451 |
| Boston Scientific | 16 | $1,372 |
| Axonics, Inc. | 5 | $218 |
| Teleflex LLC | 5 | $189 |
| Urogen Pharma, Inc. | 1 | $61 |
| Valencia Technologies Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GEMTESA$2,800
- AquaBeam Robotic System$1,876
- AMS 700 CXR RTE KIT$510
- AQUABEAM SYSTEM$149
- Solyx SIS System$147
- Bulkamid$135
- GREENLIGHT$124
- GENERAL KIDNEY STONE DISEASE$123
- UroLift$111
How this compares
$7,106 in reported general payments places this provider in the 70th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 229 | $145,646 |
| EliquisApixaban | 17 | $15,304 |
| GemtesaVibegron | 22 | $14,625 |
| Mirabegron ErMirabegron | 25 | $14,115 |
| Tamsulosin Hcl | 211 | $3,583 |
| Estradiol | 54 | $3,015 |
| Finasteride | 150 | $1,681 |
| Oxybutynin Chloride | 41 | $874 |
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $806 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 22 | $471 |
| Cephalexin | 18 | $289 |
| Doxazosin Mesylate | 15 | $237 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 55 | $237 |
| Ciprofloxacin Hcl | 50 | $221 |
| Hydroxyzine Hcl | 11 | $145 |
Paid to pharmacies, not to this prescriber.
Other urology in Charleston
- Sandip PrasadCharleston$177K
- Ian MarshallCharleston$60K
- Thomas KeaneCharleston$52K
- Stephen SavageCharleston$32K
- Matvey TsivianCharleston$18K
- John BrittonCharleston$15K
- John AdamsCharleston$15K
- Bradley SteeleCharleston$12K
- Alexander RamsayCharleston$10K
- Mark BuchananCharleston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.